Scripps Research Logo

Ulo Langel, Ph.D.

Professor Adjunct
Department of Molecular Medicine
California Campus
Scripps VIVO Scientific Profile
@scripps.edu
(858) 784-8636

Education

Ph.D. (Biochemistry (Neurochemistry)), Tartu University 1993
Ph.D. (Organic Chemistry (Bioorganic Chemistry)), Tartu University 1980

Professional Experience

2006-2017 Professor Adjunct, Chemical Physiology, The Scripps Research Institute
2005-2013 Chair, Department of Neurochemistry, Stockholm University
1997-2004 Director of Studies and Deputy Chairman, Department Neurochemistry and Neurotoxicology, Stockholm University
2001-2003 Professor of Neurochemistry and Neurotoxicology, Stockholm University
2000-2001 Associate Professor, Dorris Neuroscience Center, The Scripps Research Institute
1992-2001 Lecturer and Associate Professor, Department Neurochemistry and Neurotoxicology, Stockholm University
1987-1991 Visiting Research Fellow, Department Biochemistry, Stockholm University
1980-1989 Lecturer and Associate Professor, Tartu University

Selected References

All Publications

Saar, I., Lahe, J., Langel, K., Runesson, J., Webling, K., Jarv, J., Rytkonen, J., Narvanen, A., Bartfai, T., Kurrikoff, K. & Langel, U. Novel systemically active galanin receptor 2 ligands in depression-like behavior. (2013). Journal of Neurochemistry, 127(1), 114-123.

Webling, K. E., Runesson, J., Bartfai, T. & Langel, U. Galanin receptors and ligands. (2012). Frontiers in Endocrinology, 3, 146. PMCID: PMC3516677.

Vukojevic, V., Ming, Y., D'Addario, C., Hansen, M., Langel, U., Schulz, R., Johansson, B., Rigler, R. & Terenius, L. Mu-opioid receptor activation in live cells. (2008). FASEB Journal, 22(10), 3537-3548.

Lundstrom, L., Sollenberg, U. E., Bartfai, T. & Langel, U. Molecular characterization of the ligand binding site of the human galanin receptor type 2, identifying subtype selective interactions. (2007). Journal of Neurochemistry, 103(5), 1774-1784.

Robinson, J. K., Bartfai, T. & Langel, U. Galanin/GALP receptors and CNS homeostatic processes. (2006). CNS & Neurological Disorders-Drug Targets, 5(3), 327-334.

Lundstrom, L., Sollenberg, U., Brewer, A., Kouya, P. F., Zheng, K., Xu, X. J., Sheng, X., Robinson, J. K., Wiesenfeld-Hallin, Z., Xu, Z. Q., Hokfelt, T., Bartfai, T., et al. A galanin receptor subtype 1 specific agonist. (2005). International Journal of Peptide Research and Therapeutics, 11(1), 17-27.

Quynh, N. T. T., Islam, M. S., Floren, A., Bartfai, T., Langel, U. & Ostenson, C. G. Effects of galnon, a non-peptide galanin-receptor agonist, on insulin release from rat pancreatic islets. (2005). Biochemical and Biophysical Research Communications, 328(1), 213-220.

Kilk, K., El-Andaloussi, S., Jarver, P., Meikas, A., Valkna, A., Bartfai, T., Kogerman, P., Metsis, M. & Langel, U. Evaluation of transportan 10 in PEI mediated plasmid delivery assay. (2005). Journal of Controlled Release, 103(2), 511-523.

Lundstrom, L., Elmquist, A., Bartfai, T. & Langel, U. Galanin and its receptors in neurological disorders. (2005). Neuromolecular Medicine, 7(1-2), 157-180.

Lu, X. Y., Lundstrom, L., Langel, U. & Bartfai, T. Galanin receptor ligands. (2005). Neuropeptides, 39(3), 143-146.